019736 S70 M5 vr mqr 10211 10212 pq

Collection

Pfizer Documents (PHMPT/FDA)

Case

Pfizer Bla Submission

Sub-case

Pfizer 16 Plus Documents

Pages

Download PDF ↗ Live URL (may be dead)

Document text

FDA-CBER-2021-5683-1072736
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
Page 2
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072737
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
Page 3
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072738
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 4
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072739
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 5
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072740
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 6
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072741
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 7
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072742
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 8
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072743
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 9
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072744
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 10
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072745
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 11
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072746
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 12
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072747
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
Page 13
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072748
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 14
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072749
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
Page 15
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072750
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 16
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072751
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 17
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072752
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 18
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072753
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
Page 19
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072754
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 20
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072755
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 21
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072756
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 22
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072757
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 23
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072758
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 24
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072759
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
Page 25
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072760
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 26
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072761
SARS-CoV-2 dLIA Precision Qualification Data for Documentation re VR-MQR-10211 and VR-MQR-10212   
PFIZER CONFIDENTIAL
Page 27
090177e194aed916\Approved\Approved On: 18-Aug-2020 20:59 (GMT)
(b) (4)
FDA-CBER-2021-5683-1072762

Related across Profoundd

Oregon Climate Docs

Medford — Transportation System Plan 2018-2038 p.11
LIST OF TABLES Cont inued Number Description Page 8-1 2023 PM Peak Hour Lev el of Service Un signalized Intersection s in Medfo rd UGB ...8-2 8-2 Summary of Intersection Traffic Control Imp rovemen ts.…
Medford — Transportation System Plan 2018-2038 p.10
LIST OF TABLES Num ber Description Page 1-1 Summary of City of Medfo rd 20-year Revenu e Estimates ........................................... 1-28 2-1 Adop ted Elemen ts of The Oreg on Tran sportation P…
Grants Pass — Sustainability and Energy Action Plan p.184
REFERENCES GRANTS PASS SUSTAINABILITY AND ENERGY ACTION PLAN Endnotes 1.Taskforce Formation Document 2.City data, see Appendix II (Municipal Energy Usage Report: Baseline Projections) 3.City of Grants Pass Addendum to th…

WEF Publications

Healthcare in a Changing Climate 2025 p.44
72. Gupta, A., Dialynas, C., McLaughlin, M. & Richie, J. (2024). Advancing Innovative Treatments for Mental Health Care. Milken Institute. https://milkeninstitute.org/sites/default/files/2024-04/AdvancingInnovativeTreat…
PHSSR Policy Roadmaps for Acting Early on NCDs Synthesis Report 2025 p.113
110 Acting early on NCDs The Partnership for Health System Sustainability and ResilienceFontbonne, A., Currie, A., Tounian, P ., Picot, M.-C., Foulatier, O., Nedelcu, M., Nocca, D. (2023). Prevalence of Overweight and O…
Future of Jobs Report 2025 p.216
Contextual indicators Regional average Income Gr oup average Labour for ce par ticipation (2020) 62% Vulnerable employment (2022) 34% Share of youth not in employment, educat ion, or training (NEET)- NA Unemployment rate…

Epstein Files

EFTA01250245 — FD-0036 (Rev. ID-16.20091 UNCLASSIFIED//LES
FD-0036 (Rev. ID-16.20091 UNCLASSIFIED//LES FEDERAL BUREAU OF INVESTIGATION Import Form OFFICIAL RECORD Form Type: FD-71A - Guardian Complaint Form Date: 10/07/2021 Title:U Victim of Jeffrey Epstein Approved By: Drafted …
EFTA02455520 — From: Deepak Chopra
From: Deepak Chopra Sent: Monday, August 1, 2016 12:29 PM To: Jeff Epstein Subject: Fw: Draft OpEd piece on FDA sharing confidentially Writing this up for WSJ now 2013 Costa Del Mar Road Carlsbad, CA 92009 The Chopra Fou…
EFTA00173953 — Date: May 18, 2015
MEMORANDUM Date: May 18, 2015 To: From: SENSITIVE BUT UNCLASSIFIED Assistant Special Agent in Charge Special Operations Division Director OCDETF Fusion Center Subject: Target Profile: EPSTEIN• OFC-TP-15-12392 SODOFC-15.1…

Federal Writers' Project

[Mud, Flowers and Parental Problems]
FOLKLORE Forms to be Filled out for Each Interview NEW YORK 0/ FORMA Circumstances of Interview STATE New York NAME OF WORKER Wayne Walden ADDRESS51 Bank St. New York City DATE Aug. 26, 1938 SUBJECT MUD, FLOWERS AND PARE…
[History of career (import) of J.H. Kimbrough]
Cote/et/ H fi) 0 u41# ryi C-C'e" "I (SR at low,/ Dirs f301;40„ MIA t 4.0 )nek sal-. I 9 .9 7 MARA REESE 1.6Wtf OZ3 PLO AL we,/ y tact/us k r -e) (loss e, frabe,e0 rrrort, 72 <Z ootti 17-4./S fiZo rrt.4) C Tr a i 6 AAA.A.…
[Villa Alexandria and Jacksonville]
July 7, 1989. David ititohell, 819 Law mxohange ear. W. N. Narwiok, Lawyer, jaoksenville„ Ploritai Koss bhopherd, writer. VILLA ATAXANDRIA and JAOKSONVILLS IN 1870 1880. Mr. David Mitchell, the grandson of Alexander Mite…

Recent News

Misinformation for thee, not me? FDA had similar concerns as COVID vaccine skeptics, docs suggest
FOIA production shows agency wasn't impressed by Pfizer plan to mitigate "endotoxins," complained about insufficient cleaning in manufacturing, had no basis to claim post-vax heart inflammation was rare. Published: Decem…
FDA Approves BioNTech's Comirnaty. Pfizer COVID Shot Remains Experimental
This is a member's only feature. Please join or upgrade Originally published on www.thevaccinereaction.org by Carolyn Hendler, JD, Theresa Wrangham and Marco Cáceres On Aug. 23, 2021, the U.S. Food and Drug Administratio…
FDA Knew COVID Vaccine Safety Monitoring System Was ‘Not Sufficient,’ Latest Pfizer Documents Confirm
You must be a CHD Insider to save this article Sign Up Already an Insider? Log in The U.S. Food and Drug Administration this week released its last batch of files related to the licensing of Pfizer’s COVID-19 vaccine for…